G 2/21: how to support inventive steps in patentability

Post-published evidence can be crucial to establishing patentability. G 2/21, the European Patent Office (EPO)’s referral to the Enlarged Board of Appeal (EBA) on the question of whether post-published evidence can be used to support the concept of “inventive step”.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Wiggin’s new litigation partner deepens ‘technically complex’ offer

24 February 2026 The New York hire brings broad litigation and transactional experience, including advising clients on artificial intelligence, biotech, pharma and chemical matters.

Medtech

Could everyday hospital equipment be the next defence against counterfeit medicines?

23 February 2026 A new study suggests the equipment already found in hospitals worldwide could offer a front line against fake vaccines and insulin.

Americas

BioNTech fires shots at Moderna's next-generation vaccine

20 February 2026 The German biotech claims the newly approved vaccine infringes its mRNA patent, deepening an already complex feud with billions of dollars at stake.

More features

Generic rival blocked as AZ defends diabetes stronghold

The curtain closes on three major drug disputes

INTA: ‘Davos of IP’ will take London meeting to a ‘different level’

Squire Patton Boggs brings in tech and data expert as Ireland practice lead

The quantum advantage: IP considerations for the next generation of life sciences innovation

Rooted in rights: Lessons from plant patent infringement and invalidity cases

Goodwin targets transatlantic patent work with London hire

Bayer secures key Denmark ruling as Xarelto faces expiry pressure

G 2/21: how to support inventive steps in patentability

More on this story

Editor's picks

Editor's picks

More features